We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

106 hedge funds and large institutions have $339M invested in GenMark Diagnostics, Inc in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 21

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

0% more funds holding

Funds holding: 106 → 106 (0)

8% less capital invested

Capital invested by funds: $368M → $339M (-$29.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $49K

Holders
106
Holders Change
–
Holders Change %
0%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
45
Reduced
21
Closed
14
Calls
–
Puts
$49K
Net Calls
-$49K
Net Calls Change
+$25K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.4M
2
CCM
Cadian Capital Management
New York
+$3.44M
3
N
Nuveen
North Carolina
+$2.93M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.46M
5
BlackRock
BlackRock
New York
+$1.36M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.76M
2
JP Morgan Chase
JP Morgan Chase
New York
-$7.31M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.81M
4
SSA
Schonfeld Strategic Advisors
New York
-$1.19M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$963K
Name Holding Trade Value Shares
Change 		Change in
Stake
GIP
26
Granite Investment Partners
California
$1.99M +$929K +131,857 +75%
Citadel Advisors
27
Citadel Advisors
Florida
$1.84M -$86.8K -12,320 -4%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$1.8M -$597K -84,795 -23%
MAG
29
Millrace Asset Group
Pennsylvania
$1.61M -$622K -88,309 -26%
OAM
30
Oxford Asset Management
United Kingdom
$1.61M -$613K -87,007 -26%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.52M +$125K +17,700 +8%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.48M -$82.7K -11,730 -5%
Wells Fargo
33
Wells Fargo
California
$1.33M +$737K +104,607 +104%
Federated Hermes
34
Federated Hermes
Pennsylvania
$1.3M – – –
NIM
35
Needham Investment Management
New York
$1.23M -$356K -50,500 -21%
Squarepoint
36
Squarepoint
New York
$1.18M +$945K +134,084 +279%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$988K -$705 -100 -0.1%
Man Group
38
Man Group
United Kingdom
$948K +$16.9K +2,400 +2%
WMSA
39
Weiss Multi-Strategy Advisers
New York
$714K -$141K -20,000 -15%
Swiss National Bank
40
Swiss National Bank
Switzerland
$628K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$622K +$40.9K +5,807 +6%
William Blair & Company
42
William Blair & Company
Illinois
$605K – – –
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$544K +$31.3K +4,442 +6%
RA
44
Royce & Associates
New York
$494K – – –
AllianceBernstein
45
AllianceBernstein
Tennessee
$424K +$35.2K +5,000 +8%
WI
46
WrapManager Inc
California
$411K +$69.8K +9,909 +19%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$391K +$24K +3,400 +6%
Envestnet Asset Management
48
Envestnet Asset Management
Illinois
$361K +$392K +55,601 New
Barclays
49
Barclays
United Kingdom
$359K +$286K +40,650 +276%
MFIM
50
Mesirow Financial Investment Management
Illinois
$349K +$41.2K +5,854 +12%
1
2
3 4 5

GNMK Hedge Fund Activity: Q2 2019 in Review

106 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2019, worth a combined $339M — down 8% from $368M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new GNMK positions and 14 closed out — a net gain of 2 holders — while 45 added to existing stakes and 21 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $7.76M.

  • 106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $339M of GenMark Diagnostics, Inc stock for Q2 2019, down 8% quarter-over-quarter.
  • 16 funds opened new GenMark Diagnostics, Inc positions in Q2 2019 and 14 closed out, a net change of +2 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q2 2019 was Morgan Stanley, an estimated $10.4M added.
  • The largest GenMark Diagnostics, Inc seller in Q2 2019 was T. Rowe Price Associates, an estimated $7.76M sold.

Based on aggregated 13F filings for Q2 2019.